{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T16:45:13Z","timestamp":1793897113425,"version":"4.8.0"},"reference-count":49,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hyoscine butylbromide, also known as hyoscyamine or scopolamine, and sold under the trade name Buscopan, is an antimuscarinic agent commonly used to induce smooth muscle relaxation and reduce spasmodic activity of the gastrointestinal (GI) tract during endoscopic procedures. However, the balance between desirable and undesirable (adverse) effects is not clear when used during GI endoscopy. The Clinical Affairs Committee of the Canadian Association of Gastroenterology (CAG) conducted systematic reviews and applied the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach to develop recommendations for the use of Buscopan during GI endoscopy. To summarize, we recommend against the use of Buscopan before or during colonoscopy (strong recommendation, high certainty of evidence). We suggest against the use of Buscopan before or during gastroscopy (conditional recommendation, very low certainty of evidence). We suggest the use of Buscopan before or during ERCP (conditional recommendation, very low certainty of evidence). More research is needed to determine whether patients undergoing advanced procedures such as endoscopic mucosal resection or endoscopic submucosal dissection benefit from its use. Buscopan should be used with caution in patients with cardiac comorbidities. According to its product monograph, Buscopan is contraindicated in patients with tachycardia, angina, and cardiac failure. Thus, Buscopan should be used very cautiously in patients with these conditions, and only when the potential benefits of its use outweigh the potential risks in a particular case. Such patients require careful cardiac monitoring in an environment where resuscitation equipment and appropriately trained staff to use it are readily available. According to its product monograph, Buscopan is also contraindicated in patients with prostatic hypertrophy with urinary retention, and therefore, should be used very cautiously in such patients as well, and only when the potential benefits of its use outweigh the potential risks in a particular case. Obtaining a preprocedural history of glaucoma is unlikely to be of value when considering Buscopan use. However, in cases where Buscopan has been used, patients should be counselled postprocedurally and told to present to an emergency facility should they experience eye pain, redness, decreased vision, nausea and vomiting or headache.<\/jats:p>","DOI":"10.1093\/jcag\/gwab038","type":"journal-article","created":{"date-parts":[[2021,9,23]],"date-time":"2021-09-23T21:37:56Z","timestamp":1632433076000},"page":"259-268","source":"Crossref","is-referenced-by-count":11,"title":["Canadian Association of Gastroenterology (CAG) Position Statement on the Use of Hyoscine-<i>n<\/i>-butylbromide (Buscopan) During Gastrointestinal Endoscopy"],"prefix":"10.1093","volume":"4","author":[{"given":"Nauzer","family":"Forbes","sequence":"first","affiliation":[{"name":"Division of Gastroenterology and Hepatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levi","family":"Frehlich","sequence":"additional","affiliation":[{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Borgaonkar","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Memorial University, St John\u2019s, Newfoundland and Labrador, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5072-7599","authenticated-orcid":false,"given":"Grigorios I","family":"Leontiadis","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada"},{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Tse","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, McMaster University, Hamilton, Ontario, Canada"},{"name":"Farncombe Family Digestive Health Research Institute, McMaster University, Hamilton, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"1","key":"2021120508523163700_CIT0001","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/ajg.2014.385","article-title":"Quality indicators for colonoscopy","volume":"110","author":"Rex","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"2021120508523163700_CIT0002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/flgastro-2012-100135","article-title":"Administration of hyoscine- n-butylbromide during colonoscopy: A survey of current UK practice","volume":"3","author":"Bedford","year":"2012","journal-title":"Frontline Gastroenterol"},{"issue":"1","key":"2021120508523163700_CIT0003","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/014107688207500106","article-title":"Buscopan or glucagon for endoscopic cannulation of ampulla of vater?","volume":"75","author":"Hannigan","year":"1982","journal-title":"J R Soc Med"},{"key":"2021120508523163700_CIT0004","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","article-title":"Adverse events associated with ERCP","volume":"85","author":"Chandrasekhara","year":"2017","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"2021120508523163700_CIT0005","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.crad.2008.02.008","article-title":"Precautions to be taken by radiologists and radiographers when prescribing hyoscine-N-butylbromide","volume":"63","author":"Dyde","year":"2008","journal-title":"Clin Radiol"},{"key":"2021120508523163700_CIT0006"},{"issue":"3","key":"2021120508523163700_CIT0007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1136\/flgastro-2017-100877","article-title":"Use of intravenous hyoscine butylbromide (Buscopan) during gastrointestinal endoscopy","volume":"9","author":"Lee","year":"2018","journal-title":"Frontline Gastroenterol"},{"key":"2021120508523163700_CIT0008","first-page":"414856","article-title":"Hyoscine-N-butyl-bromide-induced hypotension and myocardial ischemia","volume":"2013","author":"Chen","year":"2013","journal-title":"Case Rep Crit Care"},{"key":"2021120508523163700_CIT0009","year":"2017"},{"issue":"3","key":"2021120508523163700_CIT0010","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0033-1358831","article-title":"Colonoscopic factors associated with adenoma detection in a national colorectal cancer screening program","volume":"46","author":"Lee","year":"2014","journal-title":"Endoscopy"},{"issue":"6","key":"2021120508523163700_CIT0011","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10350-004-0940-1","article-title":"Prospective evaluation of factors predicting difficulty and pain during sedation-free colonoscopy","volume":"48","author":"Takahashi","year":"2005","journal-title":"Dis Colon Rectum"},{"issue":"9","key":"2021120508523163700_CIT0012","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/MEG.0b013e32832357b3","article-title":"Factors associated with abdominal discomfort during colonoscopy: A prospective analysis","volume":"21","author":"Elphick","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"4","key":"2021120508523163700_CIT0013","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.gie.2011.12.010","article-title":"Hyoscine N-butylbromide does not improve polyp detection during colonoscopy: A double-blind, randomized, placebo-controlled, clinical trial","volume":"75","author":"de Brouwer","year":"2012","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"2021120508523163700_CIT0014","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3109\/00365521.2015.1083611","article-title":"The role of routinely given hyoscine-N-butylbromide in colonoscopy: A double-blind, randomized, placebo-controlled, clinical trial","volume":"51","author":"Ristikankare","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"2021120508523163700_CIT0015","doi-asserted-by":"crossref","first-page":"295","DOI":"10.14740\/gr1057w","article-title":"Impact of Hyoscine Bromide use on polyp detection rate during colonoscopy: A systematic review and meta-analysis","volume":"11","author":"Khan","year":"2018","journal-title":"Gastroenterology Res"},{"issue":"3","key":"2021120508523163700_CIT0016","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/den.12340","article-title":"Effect of hyoscine N-butylbromide on adenoma detection rate: Meta-analysis of randomized clinical trials","volume":"27","author":"Madhoun","year":"2015","journal-title":"Dig Endosc"},{"issue":"6","key":"2021120508523163700_CIT0017","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.gie.2014.05.319","article-title":"The impact of hyoscine-N-butylbromide on adenoma detection during colonoscopy: Meta-analysis of randomized, controlled studies","volume":"80","author":"Rondonotti","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"2021120508523163700_CIT0018","year":"2011"},{"issue":"7650","key":"2021120508523163700_CIT0019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: An emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"9","key":"2021120508523163700_CIT0020","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s10350-006-0560-z","article-title":"Comparison of glucagon and scopolamine butylbromide as premedication for colonoscopy in unsedated patients","volume":"49","author":"Yoshikawa","year":"2006","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2021120508523163700_CIT0021","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/00365521.2016.1228117","article-title":"Impact of nitroglycerin and glucagon administration on selective common bile duct cannulation and prevention of post-ERCP pancreatitis","volume":"52","author":"Katsinelos","year":"2017","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"2021120508523163700_CIT0022","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.gie.2007.02.052","article-title":"Sublingual L-hyoscyamine for duodenal antimotility during ERCP: A prospective randomized double-blinded study","volume":"66","author":"Lynch","year":"2007","journal-title":"Gastrointest Endosc"},{"issue":"2","key":"2021120508523163700_CIT0023","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0016-5107(97)70061-0","article-title":"A prospective, double-blind trial of L-hyoscyamine versus glucagon for the inhibition of small intestinal motility during ERCP","volume":"46","author":"Lahoti","year":"1997","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"2021120508523163700_CIT0024","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3109\/00365529509093278","article-title":"A randomized study comparing glucagon and hyoscine N-butyl bromide before endoscopic retrograde cholangiopancreatography","volume":"30","author":"Chang","year":"1995","journal-title":"Scand J Gastroenterol"},{"key":"2021120508523163700_CIT0025","doi-asserted-by":"crossref","first-page":"S655","DOI":"10.14309\/00000434-201510001-01517","article-title":"The effectiveness and strategy of glucagon for the pre-treatment of ERCP-related procedures","volume":"110","author":"Toki","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"2021120508523163700_CIT0026","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1093\/jcag\/gwaa007","article-title":"Characteristics and outcomes of ERCP at a Canadian Tertiary Centre: Initial results from a prospective high-fidelity biliary endoscopy registry","volume":"4","author":"Forbes","year":"2021","journal-title":"J Can Assoc Gastroenterol"},{"key":"2021120508523163700_CIT0027","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.gie.2016.06.051","article-title":"Adverse events associated with ERCP","volume":"85","author":"Chandrasekhara","year":"2017","journal-title":"Gastrointest Endosc"},{"issue":"7","key":"2021120508523163700_CIT0028","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1055\/a-1130-6127","article-title":"Noneffectiveness of scopolamine for facilitating detection of upper gastrointestinal neoplasia during screening esophagogastroduodenoscopy: Propensity score-matched study","volume":"52","author":"Omata","year":"2020","journal-title":"Endoscopy"},{"issue":"4","key":"2021120508523163700_CIT0029","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/00004836-199806000-00006","article-title":"Factors affecting patient tolerance of upper gastrointestinal endoscopy","volume":"26","author":"Walmsley","year":"1998","journal-title":"J Clin Gastroenterol"},{"issue":"12","key":"2021120508523163700_CIT0030","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1038\/ajg.2013.141","article-title":"Anti-adhesion therapies and the rule of 3 for rare events","volume":"108","author":"Govani","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2021120508523163700_CIT0031","year":"2016"},{"issue":"3","key":"2021120508523163700_CIT0032","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0016-5107(96)70317-6","article-title":"Premedication with intravenous antispasmodic speeds colonoscope insertion","volume":"43","author":"Saunders","year":"1996","journal-title":"Gastrointest Endosc"},{"key":"2021120508523163700_CIT0033","doi-asserted-by":"crossref","first-page":"AB229","DOI":"10.1016\/j.gie.2009.03.555","article-title":"Role of intravenous hyoscine N-Butyl Bromide at the time of colonoscopic withdrawal for polyp detection rates: A randomized, double-blinded, placebo-controlled trial","volume":"69","author":"Byun","year":"2009","journal-title":"Gastrointest Endosc"},{"issue":"1","key":"2021120508523163700_CIT0034","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0016-5107(03)02377-0","article-title":"Randomized, double-blinded, placebo-controlled trial of intravenously administered hyoscine N-butyl bromide in patients undergoing colonoscopy with patient-controlled sedation","volume":"59","author":"Mui","year":"2004","journal-title":"Gastrointest Endosc"},{"issue":"97","key":"2021120508523163700_CIT0035","first-page":"90","article-title":"Effects of Hyosine N-butyl bromide on the detection of polyps during colonoscopy","volume":"57","author":"Lee","year":"2010","journal-title":"Hepatogastroenterology"},{"issue":"10","key":"2021120508523163700_CIT0036","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1055\/s-0032-1310009","article-title":"Hyoscine butylbromide administered at the cecum increases polyp detection: A randomized double-blind placebo-controlled trial","volume":"44","author":"Corte","year":"2012","journal-title":"Endoscopy"},{"issue":"8","key":"2021120508523163700_CIT0037","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.dld.2013.01.029","article-title":"Hyoscine N-butylbromide for adenoma detection during colonoscopy: A randomized, double-blind, placebo-controlled study","volume":"45","author":"Rondonotti","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"2","key":"2021120508523163700_CIT0038","first-page":"179","article-title":"The efficacy of intravenous hyoscine-N-butylbromide during colonoscopy: A prospective, randomized, double-blind, placebo-controlled study","volume":"79","author":"Dinc","year":"2016","journal-title":"Acta Gastroenterol Belg"},{"issue":"7","key":"2021120508523163700_CIT0039","doi-asserted-by":"crossref","first-page":"395","DOI":"10.6061\/clinics\/2017(07)01","article-title":"Hyoscine butylbromide for colorectal polyp detection: Prospective, randomized, placebo-controlled trial","volume":"72","author":"Dos Santos","year":"2017","journal-title":"Clinics (Sao Paulo)"},{"issue":"6","key":"2021120508523163700_CIT0040","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0016-5107(99)70289-0","article-title":"Benefit of intravenous antispasmodic (hyoscyamine sulfate) as premedication for colonoscopy","volume":"49","author":"Marshall","year":"1999","journal-title":"Gastrointest Endosc"},{"issue":"8","key":"2021120508523163700_CIT0041","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-2004-825660","article-title":"Intravenous hyoscine as a premedication for colonoscopy: A randomized double-blind controlled trial","volume":"36","author":"Yoong","year":"2004","journal-title":"Endoscopy"},{"issue":"1","key":"2021120508523163700_CIT0042","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.amjsurg.2007.06.030","article-title":"Sublingual hyoscyamine spray as premedication for colonoscopy: A randomized double-blinded placebo-controlled trial","volume":"196","author":"Chaptini","year":"2008","journal-title":"Am J Surg"},{"key":"2021120508523163700_CIT0043","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14647273.2020.1842915","article-title":"The effect of hyoscine-N-butylbromide on pain perception during and after hysterosalpingography in infertile women: A systematic review and meta-analysis of randomised controlled trials","author":"Aboshama","year":"2020","journal-title":"Hum Fertil (Camb)"},{"issue":"1","key":"2021120508523163700_CIT0044","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1186\/s12884-020-2832-3","article-title":"The effect of hyoscine n- butylbromide on labor progress: A systematic review","volume":"20","author":"Mohaghegh","year":"2020","journal-title":"BMC Pregnancy Childbirth"},{"key":"2021120508523163700_CIT0045","first-page":"Cd009243","article-title":"Antispasmodics for labour","volume":"2013","author":"Rohwer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2021120508523163700_CIT0046","first-page":"82","article-title":"Effect of antispasmodic agents, alone or in combination, in the treatment of irritable bowel syndrome: Systematic review and meta-analysis","volume":"77","author":"Mart\u00ednez-V\u00e1zquez","year":"2012","journal-title":"Rev Gastroenterol Mex"},{"key":"2021120508523163700_CIT0047","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: Systematic review and meta-analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"issue":"11","key":"2021120508523163700_CIT0048","doi-asserted-by":"crossref","first-page":"3159","DOI":"10.1185\/03007990802472700","article-title":"Hyoscine butylbromide - a review on its parenteral use in acute abdominal spasm and as an aid in abdominal diagnostic and therapeutic procedures","volume":"24","author":"Tytgat","year":"2008","journal-title":"Curr Med Res Opin"},{"issue":"9","key":"2021120508523163700_CIT0049","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.2165\/00003495-200767090-00007","article-title":"Hyoscine butylbromide: A review of its use in the treatment of abdominal cramping and pain","volume":"67","author":"Tytgat","year":"2007","journal-title":"Drugs"}],"container-title":["Journal of the Canadian Association of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/4\/6\/259\/41504233\/gwab038.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcag\/article-pdf\/4\/6\/259\/41504233\/gwab038.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T01:36:08Z","timestamp":1673314568000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcag\/article\/4\/6\/259\/6390069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":49,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,10,12]]},"published-print":{"date-parts":[[2021,12,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jcag\/gwab038","relation":{},"ISSN":["2515-2084","2515-2092"],"issn-type":[{"value":"2515-2084","type":"print"},{"value":"2515-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,10,12]]}}}